Pancreatic cancer is predicted to be the second leading cause of cancer-related deaths by 2020.

Recently, Harvard University released a promising new study.

Researchers revealed that a chemical found in cannabis called FBL-03G has demonstrated “significant therapy potential”.

"Tumor-targeted delivery of flavonoids, derived from cannabis, enabled both local and metastatic tumor cell kill, significantly increasing survival from pancreatic cancer,” says Wilfred Ngwa, PhD, assistant professor at Harvard. “This has major significance, given that pancreatic cancer is particularly refractory to current therapies.”

Click the link to learn more.

[ Ссылка ]

свернуть